Related Experiment Video

Updated: Jun 6, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

Issues related to the management and therapy of paediatric pulmonary hypertension

I Schulze-Neick1, M Beghetti

  • 1Great Ormond Street Hospital for Sick Children, London, UK. neicki@gosh.nhs.uk

European Respiratory Review : an Official Journal of the European Respiratory Society
|December 2, 2010
PubMed

Insights

Medical services for pediatric pulmonary hypertension (PH) are growing, necessitating adapted treatment guidelines. This review discusses current data and challenges in developing effective PH treatment algorithms for children.

Area of Science:

  • Pediatric Cardiology
  • Pulmonary Medicine
  • Medical Guidelines Development

Background:

  • Increasing establishment of specialized medical services for pediatric pulmonary hypertension (PH).
  • Growing need to adapt existing PH treatment guidelines for pediatric patients.
  • Limited specific data and established treatment algorithms for PH in children.

Purpose of the Study:

  • To summarize current data on pediatric PH from registries, cohorts, and trials.
  • To discuss the optimal approach for creating a treatment algorithm for pediatric PH.
  • To highlight unanswered questions and challenges in pediatric PH management.

Main Methods:

  • Review of data from pediatric PH registries.
  • Analysis of national cohort studies on pediatric PH.
  • Evaluation of clinical trial outcomes in pediatric PH patients.

Main Results:

  • Compilation of available evidence on pediatric PH diagnosis, treatment, and follow-up.
  • Identification of key challenges in pediatric PH management.
  • Discussion of the heterogeneity of PH in the pediatric population.

Conclusions:

  • Adaptation of current PH guidelines is crucial for pediatric care.
  • Development of a tailored treatment algorithm for pediatric PH is needed.
  • Further research is essential to address knowledge gaps in pediatric PH.

More Related Videos

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment